Michael Chrissoheris
8 Papers
7 Citations
Michael Chrissoheris is an academic researcher. The author has contributed to research in topics: Mitral regurgitation & Internal medicine. The author has an hindex of 5, co-authored 8 publications.
Chat about Author
Papers
Compassionate use of the PASCAL transcatheter mitral valve repair system for patients with severe mitral regurgitation: a multicentre, prospective, observational, first-in-man study
Fabien Praz,Konstantinos Spargias,Michael Chrissoheris,Lutz Büllesfeld,Georg Nickenig,Florian Deuschl,Robert Schueler,Neil Fam,Robert Moss,Moody Makar,Robert H. Boone,Jeremy Edwards,Aris Moschovitis,Saibal Kar,John G. Webb,Ulrich Schäfer,Ted Feldman,Stephan Windecker +17 more
TL;DR: This study establishes feasibility of the Edwards PASCAL TMVr system with a high rate of technical success and reduction of mitral regurgitation severity, and further research is needed on procedural and long-term clinical outcomes.
231
Use of MitraClip for mitral valve repair in patients with acute mitral regurgitation following acute myocardial infarction: Effect of cardiogenic shock on outcomes (IREMMI Registry)
Rodrigo Estévez-Loureiro,Mony Shuvy,Maurizio Taramasso,Tomás Benito-González,Paolo Denti,Dabit Arzamendi,Marianna Adamo,Xavier Freixa,Pedro A. Villablanca,Lian Krivoshei,Neil Fam,Konstantinos Spargias,Andrew Czarnecki,Dan Haberman,Yoram Agmon,Doron Sudarsky,Isaac Pascual,Vlasis Ninios,Salvatore Scianna,Igal Moaraf,Davide Schiavi,Michael Chrissoheris,Ronen Beeri,Arthur Kerner,Estefanía Fernández-Peregrina,Mattia Di Pasquale,Ander Regueiro,Lion Poles,Andrés Íñiguez-Romo,Felipe Fernández-Vázquez,Francesco Maisano +30 more
TL;DR: In this article, the authors compared outcomes of patients who developed cardiogenic shock (CS) to those who did not (non-CS) following acute myocardial infarction (AMI) who received percutaneous mitral valve repair (PMVR) with the MitraClip device.
Salvage MitraClip in severe secondary mitral regurgitation complicating acute myocardial infarction: data from a multicentre international study.
Dan Haberman,Maurizio Taramasso,Andrew Czarnecki,Arthur Kerner,Michael Chrissoheris,Konstantinos Spargias,Lion Poles,Yoram Agmon,Salvatore Scianna,Ronen Beeri,Chaim Lotan,Francesco Maisano,Mony Shuvy +12 more
TL;DR: All patients remained symptomatic despite optimal medical therapy and were evaluated by a multidisciplinary team and were deemed high risk for surgery and therefore salvage MitraClip procedure was performed to allow stabilization and recovery.
34
•Journal Article
Acute Invasive Hemodynamic Effects of Transcatheter Aortic Valve Replacement.
Michael Chrissoheris,Antonis Ziakas,Antonis Chalapas,Stavros Chadjimiltiades,Ioannis Styliades,Charalambos Karvounis,Ioulia Nikolaou,Konstantinos Spargias +7 more
TL;DR: Successful TAVR results in immediate and sizeable improvements in SV and CI, reductions in left and right ventricular filling pressures, and marked reductions in systemic and pulmonary vascular resistances.
15
Safety and Feasibility of MitraClip Implantation in Patients with Acute Mitral Regurgitation after Recent Myocardial Infarction and Severe Left Ventricle Dysfunction
Dan Haberman,Rodrigo Estévez-Loureiro,Tomás Benito-González,Paolo Denti,Dabit Arzamendi,Marianna Adamo,Xavier Freixa,Luis Nombela-Franco,Pedro A. Villablanca,Lian Krivoshei,Neil Fam,Konstantinos Spargias,Andrew Czarnecki,Isaac Pascual,Fabien Praz,Doron Sudarsky,Arthur Kerner,Vlasis Ninios,Marco Gennari,Ronen Beeri,Leor Perl,Haim D. Danenberg,Lion Poles,Sara Shimoni,Sorel Goland,Berenice Caneiro-Queija,Salvatore Scianna,Igal Moaraf,Davide Schiavi,Claudia Scardino,Noé Corpataux,Julio Echarte-Morales,Michael Chrissoheris,Estefanía Fernández-Peregrina,Mattia Di Pasquale,Ander Regueiro,Carlos E. Vergara-Uzcategui,Andrés Íñiguez-Romo,Felipe Fernández-Vázquez,Danny Dvir,Maurizio Taramasso,Mony Shuvy,Mony Shuvy +42 more
TL;DR: In this paper, the authors conducted a multinational, collaborative data analysis from 21 centers for patients who were, within 90 days of acute myocardial infarction (MI), treated with MitraClip due to severe MR.